Safety and Efficacy of Generic Sofosbuvir and Ribavirin for Treatment-naive Genotype 2 Chronic Hepatitis C

NCT03453346 · clinicaltrials.gov ↗

NA

Phase

COMPLETED

Status

136

Enrollment

INDUSTRY

Sponsor class

Conditions

Hepatitis C, Chronic
Hepatitis C Virus Infection, Response to Therapy of

Interventions

DRUG: Sofosbuvir
DRUG: Ribavirin

Sponsor

Kawin Technology Share-holding Co., Ltd.

Collaborators

[object Object]